Cutiss

UZH article “From Lab to Life”

Fabienne Hartmann-Fritsch still feels most at home in the lab, even though she now spends more time in front of her PC than inspecting Petri dishes. In 2017, the biologist founded the spin-off CUTISS together with four other UZH scientists. Once clinical trials are complete, the spin-off plans to roll out personalized skin tissue therapy on the market – in other words, customized human skin grown in the lab. During her doctoral studies at the University Children’s Hospital Zurich, Hartmann-Fritsch started specializing in planning and executing clinical research projects involving humans and dealing with the legal framework. The transition from pure research to (communications) management was an easy one for her. “It’s immensely gratifying to now be able to apply the results of years’ worth of lab work,” she says. The innovative product that is supposed to increase the quality of life of people suffering from skin defects is called denovoSkin. In the second trial phase, the researchers will now test the safety and effectiveness of the skin replacement in various clinics. For Hartmann-Fritsch, this means extensive talks with medics, sponsors and the authorities.

Text: Alice Werner
Picture: Frank Brüderlin

Le Temps

Interview Daniela Marino “Le Temps” (French only)

«A 7 ans, je voulais déjà être scientifique»

TECHNOLOGIES MÉDICALES En 2019, seulement une société sur quatre était fondée par une femme. A la tête de la start-up zurichoise CUTISS, qui veut révolutionner la greffe pour grands brûlés, Daniela Marino prouve que l’esprit d’entreprise se décline très bien au féminin.

Read full article by following the link below.

Daniela Marino convinces jury and audience at RFS Pitch Arena

CUTISS AG wins the Audience and the Jury Award at the Redesigning Financial Services (RFS) Pitch Arena Event.

The event is designed to bring growth companies together with large investors.
In addition to matching attractive, pre-screened companies with investors, the event also has a clear educational component. To this end, the event sets out to share insights with aspiring entrepre- neurs with respect to the skills necessary to building strong business ideas and presenting them in a compelling fashion. The jury of large investors is also selected to share valuable knowledge with the intention of helping participating compa- nies grow and prosper. In this way, the event should inspire aspiring entrepreneurs and offer investors access to attractive investment opportunities.

Swiss Technology Award for CUTISS!

CUTISS AG receives the prestigious Swiss Technology Award in the category Start-ups. The Award was handed over to CEO Daniela Marino at the Swiss Innovation Forum in Basel.

The Swiss Technology Award is the most important distinction for innovation and technology transfer in Switzerland.

This sought-after prize is being awarded for the 31st time on 21 November 2019 at the Swiss Innovation Forum, which confers awards on outstanding innovations with above-average market potential and great growth opportunities in three different categories.

Read more on startupticker.com (German only)

Article in Limmattal Newspaper about CUTISS’ R&D

The Limmattaler Newspaper visited Vincent Ronfard, our Chief Innovation Officer in our lab in Schlieren. Read about CUTISS’ Research and Development in the field of skin manufacturing.
(article in German only).

“Die Fragen gehen ihm nie aus:
Vincent Ronfard forscht seit 30 Jahren, heute züchtet er für das Schlieremer Start-up Cutiss Haut für Brandwunden…”

Scroll to Top

Newsletter

Would you like to contact us as a journalist?

This website uses cookies to ensure you get the best experience on our website.